Z-0850-2021 Class I Terminated
FDA device recall Z-0850-2021 was initiated by Penumbra Inc. on December 15, 2020 and is designated Class I. Reason for recall: The catheter may become susceptible to distal tip damage during use. Distal tip damage in conjunction with pressurization of contrast injection may result in potential vessel damage, and subsequent p… The recall status is terminated (terminated May 14, 2024). Affected quantity: 0 catheters.
Recall Details
- Product Type
- Devices
- Report Date
- January 27, 2021
- Initiation Date
- December 15, 2020
- Termination Date
- May 14, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 0 catheters
Product Description
Reason for Recall
Distribution Pattern
Worldwide distribution: U.S. (nationwide) including states of: AL, AK, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO , MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, PA, Puerto Rico, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY. And O.U.S (countries) of: Canada, Chile, Colombia, Costa Rica, Dominican Republic, Hong Kong, Israel, Japan, Korea, Lebanon, Malaysia, Nepal, New Zealand, Oman, Panama, Saudi Arabia, Singapore, South Africa, Taiwan, Thailand, United Arab Emirates, and Vietnam.